Salud financiera de hoja de balance de Cameco
Salud financiera controles de criterios 4/6
Cameco tiene unos fondos propios totales de CA$6.1B y una deuda total de CA$1.1B, lo que sitúa su ratio deuda/fondos propios en 18.3%. Sus activos y pasivos totales son CA$8.7B y CA$2.6B respectivamente. Cameco El EBIT de la empresa es de CA$386.3M, por lo que su ratio de cobertura de intereses es de -5.6. Su tesorería e inversiones a corto plazo ascienden a CA$2.7B.
Información clave
32.1%
Ratio deuda-patrimonio
CA$1.96b
Deuda
| Ratio de cobertura de intereses | -4.2x |
| Efectivo | CA$566.81m |
| Patrimonio | CA$6.09b |
| Total pasivo | CA$3.84b |
| Activos totales | CA$9.93b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Cameco: Upgrading To 'Buy' After Pullback, Strong Uranium Market
Mar 18Cameco Earnings: Outlook For 2024 Is Strong
Feb 12Cameco: Uranium Prices Are White Hot
Jan 11Cameco: Time To Book Some Profits
Dec 08Cameco's Promising Outlook: Riding The Wave Of The Uranium Resurgence
Oct 31Cameco: Nuclear's Bright Future Is Already Priced In
Sep 20Cameco: Bright Near-Term Outlook With Improving Market Fundamentals, 20% Upside
Sep 12Got Uranium? Why Cameco Remains Unstoppable
Sep 03Cameco: Keeps Adding To Its Contract Portfolio (Rating Downgrade)
Aug 18Cameco: First Half Results Robust, But The Stock Is Richly Priced
Aug 03Cameco: Digging For Precious Uranium Ore
Jul 19Cameco: Uranium Price In The Short Term, Nuclear Renaissance In The Long Term (Rating Upgrade)
Jun 20Cameco: Riding The Wave Of Positive Momentum In The Uranium Sector
Jun 13Cameco Q4 2022 Earnings Preview
Feb 08Cameco Is Now Well Positioned To Become A Significant Nuclear Supplier
Feb 02Cameco: 3 Catalysts For 2023
Jan 26Cameco: A Turnaround Is En Route
Jan 17Cameco: Changing Direction, Complicating The Bull Case
Nov 15Cameco ext5ends uranium supply contract with China Nuclear International
Nov 07Cameco Q3 2022 Earnings Preview
Oct 26Cameco: Westinghouse Deal Brings Value
Oct 18Cameco's Contract Portfolio Is Positioned To Benefit Investors
Oct 06Cameco files for $1.5B securities offering
Sep 27Cameco: Nuclear Now Moving Higher, Cheaply Valued
Sep 12Cameco: Great Outlook But Too Much Of Future Growth Is Already Priced In
Aug 24Cameco: Uranium Stages A Comeback, The Market Starts To Notice
Aug 01Cameco Q2 2022 Earnings Preview
Jul 26Cameco: A Conservative Choice In A Uranium Market With Improving Fundamentals
Jul 18Cameco: Uranium For Your Portfolio, Key Development On The Cards
Jun 08Cameco: Increases 2022 Revenue Guidance, Interesting Nuclear Opportunity
May 05Cameco: Nuclear Opportunity, Dividend To Increase 50% In 2022
Apr 04Cameco: Why I Think This Uranium Front-Runner Is Going Further Up
Mar 16Cameco: Contract Mix And Macro Risk Hurt The Stock
Mar 05Cameco Is Restarting McArthur River But I'm Still Bearish
Feb 12Kazatomprom: Major Uranium Sector Player, More Attractive Than Cameco
Jan 21Cameco Stock: High Uranium Prices Are Starting To Bite
Nov 23Cameco: Get Ready For Nuclear Energy Renaissance
Oct 19Análisis de la situación financiera
Pasivos a corto plazo: CCJLos activos a corto plazo (CA$3.7B) de la empresa superan a sus pasivos a corto plazo (CA$956.4M).
Pasivo a largo plazo: Los activos a corto plazo de CCJ (CA$1.8B) no cubren sus pasivos a largo plazo (CA$2.7B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: CCJ(20%) se considera satisfactoria.
Reducción de la deuda: CCJha pasado de 30% a 32.1% en los últimos 5 años.
Cobertura de la deuda: CCJLa deuda de la empresa está bien cubierta por el flujo de caja operativo (50.4%).
Cobertura de intereses: CCJ gana más intereses de los que paga, por lo que la cobertura del pago de intereses no es preocupante.